|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,983.00 GBX | -0.03% |
|
+2.99% | +8.69% |
| 06-25 | Cooler PCE, Hotter Chips |  |
| 06-25 | Bernstein: GSK Poised for Sustainable Growth Amid 'Much More Durable' HIV Franchise; Price Target, Forecasts Up | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 104B | |||||
| 1,006B | |||||
| 589B | |||||
| 430B | |||||
| 331B | |||||
| 288B |
- Stock Market
- Stocks
- GSK Stock
- Charts GSK plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
